Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sound Energy JV completes Morocco screening study

(Sharecast News) - Sound Energy announced the successful completion of a regional screening study in Morocco on Tuesday, that identified multiple high-potential areas for natural hydrogen and helium exploration. The AIM-traded firm said the study was carried out in collaboration with Getech Group, a specialist in geoscience and resource location technologies.

It said the work formed part of a broader exploration collaboration agreement signed between Sound Energy and Getech in October last year, aimed at identifying and ultimately developing natural hydrogen and helium resources in Morocco.

The companies now planned to form a joint venture and secure exclusive exploration and exploitation rights in the target areas, with the next phase expected to involve detailed geophysical surveys and drilling activity.

"The study has yielded several high-potential targets that will now be the focus of our next phase of evaluation to refine a more targeted exploration programme," said the company's vice-president of geoscience, John Argent.

"We see this as a strong validation of our joint approach and a meaningful step forward in our strategy to establish a leading position in the emerging natural hydrogen and helium sector."

The regional study applied Getech's proprietary geological workflows to screen for subsurface conditions favourable for hydrogen and helium accumulation across Morocco.

At 1328 BST, shares in Sound Energy were up 3.7% at 0.7p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Astrazeneca secures US approval for Truqap combo in PTEN‑deficient prostate cancer
(Sharecast News) - Drugmaker Astrazeneca said on Monday that its cancer drug Truqap, used with abiraterone and prednisone, has been approved in the US as the first targeted treatment for a form of advanced prostate cancer driven by a fault in the PTEN gene.
Big Yellow sells Harrow industrial estate for £38.4m
(Sharecast News) - Big Yellow said it has sold its industrial estate in Harrow, London, for £38.4m, subject to a £2m retention from the sale price, which will be released on the satisfaction of certain conditions.
Frasers launches £166m bid for Australia's Accent Group
(Sharecast News) - Frasers Group said it had launched a bid to buy Australian sports footwear retailer Accent Group for £166m.
Oakley Capital not planning to bid for Gamma Communications
(Sharecast News) - Oakley Capital said on Friday that it does not plan to make a takeover offer for Gamma Communications.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.